Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000951080 | SCV001097443 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000951080 | SCV001908150 | benign | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26047794, 29959532, 25296721, 16688119, 27378183, 28470390) |
Fulgent Genetics, |
RCV002503877 | SCV002812474 | likely benign | Hypophosphatemic nephrolithiasis/osteoporosis 1; Fanconi renotubular syndrome 2; Hypercalcemia, infantile, 2 | 2021-10-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000951080 | SCV004011644 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | SLC34A1: BS1, BS2 |
Mayo Clinic Laboratories, |
RCV000951080 | SCV004227159 | uncertain significance | not provided | 2023-01-11 | criteria provided, single submitter | clinical testing | BS2, PM3, PM4, PS3_supporting, PS4_moderate |
OMIM | RCV000223670 | SCV000280020 | pathogenic | Hypercalcemia, infantile, 2 | 2016-10-06 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000223670 | SCV001142351 | likely pathogenic | Hypercalcemia, infantile, 2 | 2020-01-06 | no assertion criteria provided | curation | NM_003052.4:c.272_292del in the SLC34A1 gene has an allele frequency of 0.025 in European (non-Finnish) subpopulation in the gnomAD database, including 41 homozygous occurrences. However, considering the prevalence of hypercalcemia in the general population is approximately 1% to 2% (NCBI Bookshelf, Hypercalcemia), and it is not lethal, we decided not to take the allele frequency as a strong benign evidence. This variant was identified in homozygous state in a girl who presented with incidental nephrocalcinosis and polyuria (PMID: 26047794). Functional analyses confirmed the impaired trafficking of NaPi-IIa-91del7 in HEK293 cells while phosphate uptake in the Xenopus oocyte system was largely preserved (PMID: 26047794). We interpret it as Pathogenic/Likely pathogenic. ACMG/AMP criteria applied: PS3, PM3, PM4. |
MK Azim Lab, |
RCV000223670 | SCV001478333 | uncertain significance | Hypercalcemia, infantile, 2 | 2021-01-31 | no assertion criteria provided | clinical testing | |
Molecular Genetics Laboratory, |
RCV000223670 | SCV004708193 | likely pathogenic | Hypercalcemia, infantile, 2 | 2024-03-08 | no assertion criteria provided | clinical testing |